ProPhase Labs Schedules an Investor Conference Call for Tuesday, January 10th at 4:30 PM
DOYLESTOWN, PA – January 9, 2017 - ProPhase Labs (NASDAQ: PRPH) announced earlier today an agreement to sell its Cold-EEZE® cold remedy brand. A conference call will be held on January 10th, at 4:30pm EST. ProPhase Labs Chairman and CEO, Ted Karkus will provide a company overview of the agreement. There will be a question and answer session following initial remarks.
The conference call will be webcast live at:
https://engage.vevent.com/rt/prophaselabsinc_ao~49627472 at 4:30 PM (EDT) on
Tuesday, January 10, 2017.
Participants wishing to ask questions may access the live call by dialing (844) 301-0501 conference ID # 49627472. A replay of the conference call will be available for 90 days on the company website www.ProPhaseLabs.com.